There’s not much commentary on the outlook, or how they intend to create shareholder value. Just feels slightly half hearted.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025